- Home
- CRDF vs EML Comparison
CRDF vs EML Comparison
Compare CRDF & EML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- EML
- Stock Information
- Founded
- CRDF 1999
- EML 1858
- Country
- CRDF United States
- EML United States
- Employees
- CRDF N/A
- EML N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- EML Industrial Machinery/Components
- Sector
- CRDF Health Care
- EML Consumer Discretionary
- Exchange
- CRDF Nasdaq
- EML Nasdaq
- Market Cap
- CRDF 144.4M
- EML 146.7M
- IPO Year
- CRDF N/A
- EML N/A
- Fundamental
- Price
- CRDF $2.05
- EML $25.39
- Analyst Decision
- CRDF Strong Buy
- EML
- Analyst Count
- CRDF 5
- EML 0
- Target Price
- CRDF $11.10
- EML N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- EML 13.7K
- Earning Date
- CRDF 11-06-2025
- EML 11-04-2025
- Dividend Yield
- CRDF N/A
- EML 1.74%
- EPS Growth
- CRDF N/A
- EML N/A
- EPS
- CRDF N/A
- EML N/A
- Revenue
- CRDF $545,000.00
- EML $269,054,445.00
- Revenue This Year
- CRDF N/A
- EML $1.56
- Revenue Next Year
- CRDF N/A
- EML $7.00
- P/E Ratio
- CRDF N/A
- EML $14.13
- Revenue Growth
- CRDF N/A
- EML 1.30
- 52 Week Low
- CRDF $1.90
- EML $19.06
- 52 Week High
- CRDF $5.64
- EML $35.03
- Technical
- Relative Strength Index (RSI)
- CRDF 36.50
- EML 62.12
- Support Level
- CRDF $2.03
- EML $23.50
- Resistance Level
- CRDF $2.27
- EML $24.50
- Average True Range (ATR)
- CRDF 0.12
- EML 0.73
- MACD
- CRDF 0.04
- EML 0.17
- Stochastic Oscillator
- CRDF 31.91
- EML 97.02
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.